Back to Article

The association between serum α1-AGP and chronic kidney disease among US female ages 20 to 49 years: Results from the 2015-2018 National Health and Nutrition Survey

Current Research in Public Health | Vol 5, Issue 1

Table 1. Baselinecharacteristics of the study participants.

CharacteristicsTotal (n = 2137)Serum Alpha-1-Acid Glycoprotein (g/L)p
Q1 (n = 534)Q2 (n = 529)Q3 (n = 538)Q4 (n = 536)
α1-AGP, g/L0.82±0.20.50±0.10.70±0.00.80±0.01.10±0.2<0.001
Age, years34.6 ± 8.534.3 ± 8.534.4 ± 8.834.8 ± 8.435.1 ± 8.50.381
Race, n (%)     0.219
Non-Hispanic White686 (32.1)156 (29.2)166 (31.4)172 (32.0)192 (35.8) 
Non-Hispanic Black431 (20.2)115 (21.5)105 (19.8)99 (18.4)112 (20.9) 
Mexican American391 (18.3)105 (19.7)99 (18.7)110 (20.4)77 (14.4) 
Other Race629 (29.4)158 (29.6)159 (30.1)157 (29.2)155 (28.9) 
Educational level, n (%)     0.308
High school or less151 (7.1)37 (6.9)46 (8.7)37 (6.9)31 (5.8) 
Some College615 (28.8)153 (28.7)154 (29.1)167 (31.0)141 (26.4) 
College or above1370 (64.1)344 (64.4)329 (62.2)334 (62.1)363 (67.9) 
Marital status, n (%)     0.121
Married or living with partner1271 (59.5)322 (60.3)298 (56.3)340 (63.2)311 (58.1) 
Living alone865 (40.5)212 (39.7)231 (43.7)198 (36.8)224 (41.9) 
Hypertension, n (%)339 (15.9)72 (13.5)84 (15.9)92 (17.1)91 (17.0)0.333
Diabetes, n (%)115 (5.4)32 (6.0)26 (4.9)28 (5.2)29 (5.4)0.887
Physical activity, n (%)     0.060
Sedentary1184 (55.5)284 (53.2)280 (52.9)307 (57.1)313 (58.6) 
Moderate551 (25.8)137 (25.7)158 (29.9)139 (25.8)117 (21.9) 
Vigorous400 (18.7)113 (21.2)91 (17.2)92 (17.1)104 (19.5) 
Smoking status, n (%)     0.251
Never1491 (69.8)381 (71.3)381 (72.0)368 (68.5)361 (67.5) 
Former258 (12.1)60 (11.2)63 (11.9)75 (14.0)60 (11.2) 
Current386 (18.1)93 (17.4)85 (16.1)94 (17.5)114 (21.3) 
BMI, kg/m230.0 ± 8.130.0 ± 7.830.0 ± 8.129.9 ± 8.230.0 ± 8.40.998
SBP, mmHg114.7 ± 13.4114.3 ± 12.6115.2 ± 13.1114.8 ± 13.4114.5 ± 14.20.751
DBP, mmHg69.9 ± 10.669.5 ± 10.469.4 ± 11.170.2 ± 10.070.3 ± 10.80.334
WBC, *109/L 7.7 ± 2.36.9 ± 2.07.6 ± 2.17.6 ± 2.08.8 ± 2.6<0.001
HGB, g/dL13.0 ± 1.312.9 ± 1.213.0 ± 1.213.1 ± 1.313.0 ± 1.50.289
eGFR, mL/min/1.73m2 111.7 ± 17.9113.4 ± 18.2112.5 ± 18.2112.0 ± 17.5109.1 ± 17.5<0.001
ACR, mg/g7.4 (5.1, 12.4)7.4 (5.4, 12.6)7.8 (5.4, 13.5)7.6 (5.1, 12.4)7.0 (4.8, 10.9)0.005
Vitamin D, nmol/L56.3 ± 25.554.6 ± 24.356.4 ± 23.955.2 ± 26.759.1 ± 27.00.020
ALB, g/L41.0 ± 3.741.2 ± 3.941.0 ± 3.841.0 ± 3.440.9 ± 3.90.711
Uric acid, umol/L 268.9 ± 67.9245.9 ± 58.2260.1 ± 58.0274.2 ± 65.3295.3 ± 78.1<0.001
BUN, mmol/L4.2 ± 1.44.2 ± 1.34.1 ± 1.24.3 ± 1.74.2 ± 1.30.364
Bicarbonate, mmol/L24.0 ± 2.324.1 ± 2.324.0 ± 2.123.9 ± 2.324.0 ± 2.20.448
Calcium, mmol/L2.3 ± 0.12.3 ± 0.12.3 ± 0.12.3 ± 0.12.3 ± 0.10.542
Phosphorus, mmol/L1.2 ± 0.21.2 ± 0.21.2 ± 0.21.2 ± 0.21.2 ± 0.20.006
Cholesterol, mmol/L 4.8 ± 1.04.8 ± 1.04.8 ± 1.04.8 ± 1.04.7 ± 0.90.103
HDL, mmol/L1.5 ± 0.41.7 ± 0.41.5 ± 0.41.4 ± 0.41.3 ± 0.4<0.001
Triglycerides, mmol/L 1.4 ± 0.91.1 ± 0.81.3 ± 0.91.4 ± 0.91.6 ± 0.9<0.001
HbA1c, %5.5 ± 0.95.3 ± 0.65.4 ± 0.85.6 ± 0.95.7 ± 1.0<0.001
Folate, nmol/L1114.9 ± 459.11090.8 ± 417.61100.4 ± 438.51089.3 ± 427.21179.0 ± 537.90.003
hs-CRP, mg/L2.4 (0.8, 5.4)0.7 (0.4, 2.0)1.4 (0.7, 3.4)2.8 (1.4, 5.3)6.3 (3.3, 11.6)<0.001
Ferritin, ug/L41.0 (20.5, 75.5)36.8 (19.4, 69.5)39.6 (20.7, 72.7)42.5 (21.5, 76.8)48.0 (20.9, 83.0)0.015

α1-AGP, Serum Alpha-1-Acid Glycoprotein; BMI, Body Mass Index; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; WBC, White Blood Cell count; HGB, Hemoglobin; eGFR, Estimated Glomerular Filtration Rate; ACR, Albumin-to-Creatinine Ratio; ALB, Albumin; BUN, Blood Urea Nitrogen; HDL, High-Density Lipoprotein; HbA1c, Hemoglobin A1c; hs-CRP, High-Sensitivity C-Reactive Protein.